Drugs / PF-07259955
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05206604 | Feb → Aug 2022 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-07259955 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05206604 ↗ |
| Route | Topical | “topically administered PF-07295324 and PF-07259955” NCT05206604 ↗ |